Effects of developmental exposure to diethylstilbestrol (des) in rodents: Clues for other environmental estrogens

APMIS, Supplement

Volumn 109, Issue 103, 2001, Pages

  Newbold, R R ^a   Schonfelder G ^a   Ashby, J ^a   Russo, J ^a   Huff, J ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

Cancer; Diethylstilbestrol; Environmental estrogens; Estrogen receptor; Transgenerational carcinogenesis

Indexed keywords

DIETHYLSTILBESTROL;

CANCER; CARCINOGENESIS; CONFERENCE PAPER; DRUG EFFECT; DRUG MECHANISM; ENDOCRINE SYSTEM; ENVIRONMENTAL EXPOSURE; ESTROGEN ACTIVITY; FERTILITY; HUMAN; PRENATAL EXPOSURE; PRIORITY JOURNAL;

EID: 0034918037     PISSN: 0903465X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (50)

1. Developmental effects of endocrine-disrupting chemicals in wildlife and humans
2. The fragile fetus
3. Adenocarcinoma of the vagina. Association of maternal stilbestrol therapy with tumor appearance in young women
4. Fertility in men exposed prenatally to diethylstilbestrol
5. Occurrence of tumours in the descendants of CBA male mice prenatally treated with diethylstilbestrol
6. Proliferative lesions and reproductive tract tumors in male descendants of mice exposed developmentally to diethylstilbestrol
7. Increased tumors but uncompromised fertility in the female descendants of mice exposed developmentally to diethylstilbestrol
8. Tumors of female offspring of mice exposed prenatally to diethylstilbestrol
9. Transplacental hormonal carcinogenesis: Diethylstilbestrol as an example
10. Diethylstilbestrol associated defects in murine gential tract development
11. Cellular and molecular effects of developmental exposure to diethylstilbestrol: Implications for other environmental estrogens
12. Reproductive tract lesions in male mice exposed prenatally to diethylstilbestrol
13. Long-term effects on the female mouse genital tract associated with prenatal exposure to diethylstilbestrol
14. Reduced fertility in female mice exposed transplacentally to diethylstilbestrol (DES)
15. Prenatal diethylstilbestrol exposure in the mouse: Effects on ovarian histology and steroidogenesis in vitro
16. Exposure to diethylstilbestrol during pregnancy permanently alters the ovary and oviduct
17. Developmentally arrested oviduct: A structural and functional defect in mice following prenatal exposure to diethylstilbestrol
18. Cancer risk in women exposed to diethylstilbestrol in utero
19. Neonatal estrogen treatment and epithelial abnormalities in the cervicovaginal epithelium of adult mice
20. Adenosis-like lesions and other cervicovaginal abnormalities in mice treated perinatally with estrogen
21. Occurrence of permanent changes in vaginal and uterine epithelia in mice treated neonatally with progestin, estrogen and aromatizable or non-aromatizable androgens
22. Uterine adenocarcinoma in mice following developmental treatment with estrogens: A model for hormonal carcinogenesis
23. Vaginal adenosis and adenocarcinoma in mice exposed prenatally or neonatally to diethylstilbestrol
24. Morphological and functional consequences of prenatal exposure to diethylstilbestrol in the rat
25. Histologic, morphometric, and immunocytochemical analysis of myometrial development in rats and mice: II. Effects of DES on development
26. Etiology of DES-induced uterine tumors in the Syrian hamster
27. Endometrial hyperplasia and apoptosis following neonatal diethylstilbestrol exposure and subsequent estrogen stimulation in both host and transplanted hamster uteri
28. A conserved Hox axis in the mouse and human female reproductive system: Late establishment and persistent adult expression of the Hoxa cluster genes
29. Abdominal B (AbdB) Hoxa genes: Regulation in adult uterus by estrogen and progesterone and repression in mullerian duct by the synthetic estrogen diethylstilbestrol (DES)
30. In utero diethylstilbestrol (DES) exposure alters Hox gene expression in the developing mullerian system
31. Msxl (Hox-7.1) in the adult mouse uterus: Cellular interactions underlying regulation of expression
32. Developmental exposure to diethylstilbestrol elicits demethylation of estrogen-responsive lactoferrin gene in mouse uterus
33. Epidermal growth factor receptor levels in reproductive organs of female mice exposed neonatally to diethylstilbestrol
34. Exposure to diethylstilbestrol during a critical developmental period of the mouse reproductive tract leads to persistent induction of two estrogen-regulated genes
35. Neonatal diethylstilbestrol treatment alters the estrogen-regulated expression of both cell proliferation and apoptosis-related proto-oncogenes (c-jun, c-fos, c-myc, bax, bcl-2, and bcl-x) in the hamster uterus
36. Accelerated onset of uterine tumors in transgenic mice with aberrant expression of the estrogen receptor after neonatal exposure to diethylstilbestrol
37. Estrogen receptor variant expression in transgenic mice accelerates the appearance of hormonally-induced uterine tumors
38. Estrogen receptor (ER) alpha knockout mice do not respond to estrogen
39. Induction of uterine adenocarcinoma in CD-1 mice by catechol estrogens
40. Induction of uterine tumors in mice by catecholestrogens: Implications for human mammary and uterine oncogenesis
41. Estrogen-dependent gene regulation by an oxidative metabolite of diethylstilbestrol, diethylstilbestrol-4′,4″-quinone
42. Induction of uterine adenocarcinoma in mice treated neonatally with genistein
43. Uterine carcinoma in mice treated neonatally with tamoxifen
44. Low dose effects of endocrine disruptors - A challenge for risk assessment